Tokyo, Japan and Cambridge, UK, 14 February 2025 - Nxera Pharma Co., Ltd. ("Nxera” or "the Company”; TSE 4565) provides an ...

A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

The pharma companies made drugs that could help patients and spent lots of time telling doctors which drugs to give to who. Then payers came along and started scrutinising how much was being spent ...

Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...

According to a survey by GlobalData, the parent company of Pharmaceutical Technology, AI is considered the most disruptive technology among businesses, including in the healthcare industry. The 2024 ...

"These companies will have to comply with the revised Schedule M requirements as per the plan submitted by them," a senior official told ET. As per the notification, a company's director, proprietor ...

When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals KNSA-1.57%decrease; red down pointing triangle, its scientists thought they had a future lung medicine in their ...

3382.T Seven & i Holdings Co., Ltd.